Home   ->   news   ->   Press Releases

Press Releases

WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations

June 22, 2009 – Shanghai, China – WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Felix Hsu has been appointed Senior Vice President of WuXi AppTec U.S.
 
Prior to joining WuXi, Mr. Hsu worked at Medtronic for 14 years in positions of increasing responsibility. He has broad experience as a product manager and business leader, serving as Director of Heart Valve Worldwide Marketing; Vice President of Business Excellence; Vice President of Cardiac Surgery for Asia Pacific, based in Hong Kong; and Vice President of Supply Chain Integration based in Minneapolis. Prior to working at Medtronic, he served in product management, sales management, and strategic planning roles at Abbott Laboratories and as a business manager at Sabratek. In these roles, he was successful in driving revenue growth through effective product management and in implementing strategies to improve operational excellence and reduce costs.
 
In his new role, Mr. Hsu will be responsible for WuXi's U.S. business. A significant portion of U.S. revenues are derived from serving the medical device industry, where Mr. Hsu has extensive experience. He will report to Edward Hu, Chief Operating Officer, acting Chief Financial Officer, and current head of U.S. operations.
 
"I am very pleased to welcome Felix on board as we continue to strengthen our U.S. management team," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "Our U.S. operations offer a range of testing services critical to the successful development and regulatory approval of new biologics and medical devices. We expect our U.S. business will grow under Felix's leadership."
  
Mr. Hsu received a bachelor's degree in Electrical Engineering from General Motors Institute and an MBA from the University of Michigan.


About WuXi AppTec and WuXi PharmaTech
WuXi AppTec is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi AppTec provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi AppTec's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi AppTec is an operating subsidiary of WuXi PharmaTech traded under NYSE symbol WX, formally WuXi PharmaTech (Cayman) Inc. For more information, please visit: http://www.wuxiapptec.com.

back to top